Selectivity Profiling and Biological Activity of Novel β-Carbolines as Potent and Selective DYRK1 Kinase Inhibitors
出版年份 2015 全文链接
标题
Selectivity Profiling and Biological Activity of Novel β-Carbolines as Potent and Selective DYRK1 Kinase Inhibitors
作者
关键词
Kinase inhibitors, Phosphorylation, Protein kinases, Cell viability testing, HeLa cells, Tyrosine kinases, Cell cultures, In vitro kinase assay
出版物
PLoS One
Volume 10, Issue 7, Pages e0132453
出版商
Public Library of Science (PLoS)
发表日期
2015-07-21
DOI
10.1371/journal.pone.0132453
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A
- (2015) Hannes Falke et al. JOURNAL OF MEDICINAL CHEMISTRY
- A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologiesin vitro
- (2015) Séverine Coutadeur et al. JOURNAL OF NEUROCHEMISTRY
- Chromatin-wide Profiling of DYRK1A Reveals a Role as a Gene-Specific RNA Polymerase II CTD Kinase
- (2015) Chiara Di Vona et al. MOLECULAR CELL
- First Selective Dual Inhibitors of Tau Phosphorylation and Beta-Amyloid Aggregation, Two Major Pathogenic Mechanisms in Alzheimer’s Disease
- (2014) Marica Mariano et al. ACS Chemical Neuroscience
- Computational & experimental evaluation of the structure/activity relationship of β-carbolines as DYRK1A inhibitors
- (2014) Binia Drung et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The Down syndrome-related protein kinase DYRK1A phosphorylates p27Kip1and Cyclin D1 and induces cell cycle exit and neuronal differentiation
- (2014) Ulf Soppa et al. CELL CYCLE
- DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies
- (2014) Walter Becker et al. CNS & Neurological Disorders-Drug Targets
- A Form of the Metabolic Syndrome Associated with Mutations in DYRK1B
- (2014) Ali R. Keramati et al. NEW ENGLAND JOURNAL OF MEDICINE
- Design and Synthesis of a Library of Lead-Like 2,4-Bisheterocyclic Substituted Thiophenes as Selective Dyrk/Clk Inhibitors
- (2014) Christian Schmitt et al. PLoS One
- Overexpression of Dyrk1A Is Implicated in Several Cognitive, Electrophysiological and Neuromorphological Alterations Found in a Mouse Model of Down Syndrome
- (2014) Susana García-Cerro et al. PLoS One
- Hydroxybenzothiophene Ketones Are Efficient Pre-mRNA Splicing Modulators Due to Dual Inhibition of Dyrk1A and Clk1/4
- (2014) Christian Schmitt et al. ACS Medicinal Chemistry Letters
- New Perspectives of Dyrk1A Role in Neurogenesis and Neuropathologic Features of Down Syndrome
- (2014) Joongkyu Park et al. Experimental Neurobiology
- Kinase Drug Discovery – What’s Next in the Field?
- (2013) Philip Cohen et al. ACS Chemical Biology
- A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery
- (2013) Yinghong Gao et al. BIOCHEMICAL JOURNAL
- A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr286, not Thr288
- (2013) Anne L. Ashford et al. BIOCHEMICAL JOURNAL
- Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases
- (2013) Giorgio Cozza et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Mechanism of dual specificity kinase activity of DYRK1A
- (2013) Agnes Walte et al. FEBS Journal
- Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans
- (2013) Rafael De la Torre et al. MOLECULAR NUTRITION & FOOD RESEARCH
- NGF Upregulates the Plasminogen Activation Inhibitor-1 in Neurons via the Calcineurin/NFAT Pathway and the Down Syndrome-Related Proteins DYRK1A and RCAN1 Attenuate This Effect
- (2013) Georgios C. Stefos et al. PLoS One
- Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer’s?
- (2012) Breland Smith et al. ACS Chemical Neuroscience
- Structure–activity relationship study of beta-carboline derivatives as haspin kinase inhibitors
- (2012) Gregory D. Cuny et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control
- (2012) Walter Becker CELL CYCLE
- Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B
- (2012) Tania Tahtouh et al. JOURNAL OF MEDICINAL CHEMISTRY
- A public-private partnership to unlock the untargeted kinome
- (2012) Stefan Knapp et al. Nature Chemical Biology
- Down syndrome: the brain in trisomic mode
- (2012) Mara Dierssen NATURE REVIEWS NEUROSCIENCE
- Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome
- (2012) Xavier Altafaj et al. NEUROBIOLOGY OF DISEASE
- Wnt Signaling Orchestration with a Small Molecule DYRK Inhibitor Provides Long-Term Xeno-Free Human Pluripotent Cell Expansion
- (2012) Kouichi Hasegawa et al. Stem Cells Translational Medicine
- Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin
- (2011) D Huertas et al. ONCOGENE
- Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)
- (2010) Tatyana Adayev et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Structure–activity relationship study of acridine analogs as haspin and DYRK2 kinase inhibitors
- (2010) Gregory D. Cuny et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Probing the Probes: Fitness Factors For Small Molecule Tools
- (2010) Paul Workman et al. CHEMISTRY & BIOLOGY
- DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles
- (2010) Sergi Aranda et al. FASEB JOURNAL
- MNB/DYRK1A as a multiple regulator of neuronal development
- (2010) Francisco J. Tejedor et al. FEBS Journal
- Activation, regulation, and inhibition of DYRK1A
- (2010) Walter Becker et al. FEBS Journal
- The role of DYRK1A in neurodegenerative diseases
- (2010) Jerzy Wegiel et al. FEBS Journal
- The art of the chemical probe
- (2010) Stephen V Frye Nature Chemical Biology
- Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
- (2010) Yasushi Ogawa et al. Nature Communications
- Guidelines for the effective use of chemical inhibitors of protein function to understand their roles in cell regulation: Table 1
- (2009) Philip Cohen BIOCHEMICAL JOURNAL
- Insights into protein kinase regulation and inhibition by large scale structural comparison
- (2009) Jeyanthy Eswaran et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Haspin: a newly discovered regulator of mitotic chromosome behavior
- (2009) Jonathan M. G. Higgins CHROMOSOMA
- Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation
- (2009) Nora Göckler et al. FEBS Journal
- Targeting Dyrk1A with AAVshRNA Attenuates Motor Alterations in TgDyrk1A, a Mouse Model of Down Syndrome
- (2008) Jon Ortiz-Abalia et al. AMERICAN JOURNAL OF HUMAN GENETICS
- The down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4
- (2008) J.H. Sitz et al. NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search